Marburg virus is a highly dangerous filovirus (in the same family as Ebola) that causes Marburg virus disease, a rare but often deadly form of viral haemorrhagic fever in humans.

What is the Marburg virus?

Marburg virus is an RNA virus that belongs to the Filoviridae family, which also includes Ebola viruses. It causes Marburg virus disease (MVD), formerly called Marburg haemorrhagic fever, a severe illness with a case fatality rate that has ranged from about 24% to as high as 88% in different outbreaks.

The virus was first recognized in 1967 after simultaneous outbreaks of severe haemorrhagic fever occurred in laboratory workers in Marburg and Frankfurt (Germany) and Belgrade, linked to African green monkeys imported from Uganda.

How do people get infected?

The main natural reservoir is thought to be certain fruit bats, especially the Egyptian rousette bat (Rousettus aegyptiacus). Human infection usually starts with prolonged exposure in mines, caves, or areas where these bats roost, or sometimes via infected non‑human primates.

Once in humans, the virus spreads through:

  • Direct contact with blood or other body fluids (vomit, faeces, urine, saliva, respiratory secretions) of an infected person.
  • Contact with objects or surfaces contaminated with these fluids, such as bedding or clothing.
  • Certain sexual contact, as infectious virus can persist in semen for weeks after recovery.
  • Handling bodies during funerals without proper protection.

It does not spread through the air in the way seasonal flu does, and transmission usually requires close, unprotected contact.

Symptoms and disease course

The incubation period (time from infection to symptoms) ranges from about 2 to 21 days.

Early symptoms often look like a sudden, severe flu:

  • High fever and chills.
  • Severe headache and profound malaise (feeling extremely unwell).
  • Muscle aches and pains.

Within a few days, symptoms can escalate:

  • Nausea, vomiting, abdominal pain, and severe watery diarrhoea.
  • Non‑itchy rash, often between day 2 and 7 after symptom onset.

In more severe cases, from about day 5 onwards, patients may develop:

  • Bleeding from the nose, gums, or at injection/IV sites, and blood in vomit or stool.
  • Signs of shock, liver failure, multi‑organ dysfunction, and sometimes confusion, irritability, or aggression due to central nervous system involvement.

Because early signs mimic other diseases like malaria, typhoid, or Ebola, laboratory testing in specialized facilities is needed to confirm the diagnosis.

How deadly is it, and is there a cure?

Marburg virus disease is considered one of the most severe viral illnesses known. Across recorded outbreaks, the average case fatality rate is around 50%, with different events ranging from about 24% to 88% depending on the setting and level of care.

There are currently no fully approved specific antivirals or widely available licensed vaccines for Marburg virus, although several candidates are in development and have entered clinical trials. Treatment focuses on:

  • Early supportive care : aggressive fluid and electrolyte replacement, maintaining blood pressure, and treating secondary infections.
  • Managing complications like bleeding, organ failure, and shock in intensive care settings.

Early, high‑quality supportive care significantly improves the chances of survival.

Where has it appeared and why is it a “trending topic”?

Marburg outbreaks and sporadic cases have been documented mostly in parts of sub‑Saharan Africa, including Angola, Democratic Republic of the Congo, Kenya, South Africa (linked to travel), and other countries where fruit bat reservoirs live. Outbreaks tend to be relatively small compared with major pandemics, but because of the virus’s lethality and its similarity to Ebola, even a handful of cases can trigger intense public and media attention.

In recent years, isolated outbreaks and alerts in African countries have driven spikes in online searches, forum discussions, and news coverage about “what is the Marburg virus” and “latest news,” especially when international health agencies issue notices or travel‑related advisories. Conversations often focus on whether it could spread globally, how it compares to Ebola, and what preparedness measures are in place—topics that public health organizations monitor closely and respond to with risk communication and outbreak control measures.

Quick FAQ style recap

  • What is the Marburg virus?
    A filovirus that causes Marburg virus disease, a severe haemorrhagic fever similar to Ebola.
  • Where does it come from?
    Mainly from fruit bats (especially Rousettus species) and sometimes non‑human primates, with human‑to‑human spread via body fluids once introduced.
  • How does it spread between people?
    Through direct contact with blood or other body fluids of infected individuals, contaminated surfaces, or bodies, and via some sexual contact; it does not spread easily through casual contact.
  • What are the main symptoms?
    Sudden high fever, severe headache, muscle pain, followed by vomiting, diarrhoea, abdominal pain, rash, and in severe cases internal and external bleeding and organ failure.
  • Is there a vaccine or cure yet?
    No widely licensed vaccine or specific antiviral treatment yet, but supportive care—especially early—is critical and can save lives.
  • Should people outside outbreak areas be worried?
    For most people globally, the risk remains very low, but health systems and international agencies keep a close watch and respond quickly to contain outbreaks at their source.

Information gathered from public forums or data available on the internet and portrayed here.